FDARA Section 710 required the FDA to examine the quality, safety, and effectiveness of medical device servicing.
That included servicing performed by:
- Original equipment manufacturers
- Independent service organizations
- Healthcare facilities
- In-house biomedical technicians
- Other third-party service providers
The FDA delivered its report in 2018.
Its findings remain important for anyone who owns, repairs, or services reusable medical equipment.
However, the report is often oversimplified.
It did not say every independent repair is safe.
It did not say servicing is unregulated.
And it did not create a special exemption for third-party repair companies.
What it actually said is more useful.
What Is FDARA Section 710?
FDARA stands for the Food and Drug Administration Reauthorization Act of 2017.
Section 710 directed the FDA to report on the continued quality, safety, and effectiveness of medical devices with respect to servicing.
The agency reviewed information from:
- Public workshops
- Stakeholder comments
- Complaints
- Adverse-event reports
- Available objective evidence
The question was whether medical device servicing, especially third-party servicing, created a public-health concern that required additional federal regulation.
What Did the FDA Find?
The FDA reached several important conclusions.
1. The Evidence Did Not Support New Burdensome Servicing Rules
The FDA said the available objective evidence was not sufficient to show a widespread public-health problem related to medical device servicing that would justify additional or different burdensome regulatory requirements at that time.
That is an important distinction.
The FDA did not say poor servicing never occurs.
It said the evidence did not show a widespread problem large enough to justify a new regulatory framework for servicing.
2. Both OEM and Third-Party Servicing Can Be High Quality
The FDA also found evidence that many OEMs and third-party organizations provide:
- High-quality service
- Safe service
- Effective service
So, independent servicing was not treated as inherently unsafe simply because the technician did not work for the original manufacturer.
The quality of the actual work matters.
3. Third-Party Servicing Is Important to Healthcare
One of the strongest findings in FDARA Section 710 was the FDA’s recognition that continued access to third-party repair and servicing is important to the U.S. healthcare system.
Medical equipment may remain in service for many years.
During that time, owners need access to:
- Maintenance
- Repairs
- Replacement parts
- Technical support
- Qualified technicians
OEM service is one option.
Independent service may be another.
Servicing and Remanufacturing Are Not the Same Thing
This may be the most important part of the discussion.
The FDA found that many complaints described as problems with “servicing” actually involved activities that were closer to remanufacturing.
Those are different activities.
Servicing
FDA describes servicing as repair or maintenance performed after distribution to return a finished device to:
- Its original safety specifications
- Its original performance specifications
- Its original intended use
For example, repairing a failed component and restoring the machine to its established performance may be servicing.
Remanufacturing
Remanufacturing goes further.
It involves work that significantly changes the device’s:
- Performance specifications
- Safety specifications
- Intended use
That distinction matters because remanufacturing may trigger additional FDA requirements.
Calling yourself a “service company” does not decide the issue.
The work actually performed does.
Why This Matters for Laser Repair
For an independent medical or aesthetic laser service company, the goal of a repair should normally be straightforward:
Restore the machine to its established safety and performance specifications.
That may involve:
- Component repair
- Preventative maintenance
- Optical service
- Cooling-system repair
- Electronics repair
- Handpiece service
- Output verification where appropriate
However, changing the fundamental performance or intended use of a device can raise a different regulatory question.
That is why documentation matters.
Does FDARA Section 710 Require OEM Service?
No.
FDARA Section 710 did not create a federal rule requiring clinics to use only the original manufacturer for routine medical-device servicing.
The FDA’s report actually recognized the importance of continued access to third-party service organizations.
However, that does not mean every independent company is equally qualified.
A clinic should still evaluate:
- Technician experience
- Diagnostic ability
- Parts quality
- Service documentation
- Testing methods
- Warranty
- Safety procedures
There may also be warranty, contract, state, facility, or other requirements that affect a particular machine or practice.
Does FDA Approval Mean a Third-Party Servicer Is “FDA Certified”?
Be careful with that phrase.
The FDARA report did not create an FDA certification program for independent medical-device service companies.
So, an independent service provider should not use the report to imply:
“FDA approved our company.”
That is not what Section 710 means.
Instead, the report addresses the broader regulatory treatment of medical-device servicing.
What Did FDA Recommend After the Report?
The FDA did not simply publish the report and stop there.
It identified several areas for continued work.
These included:
- Promoting quality-management principles
- Clarifying servicing versus remanufacturing
- Improving cybersecurity practices
- Developing better evidence about servicing quality and safety
Those issues remain relevant today.
FDA Later Clarified Servicing vs. Remanufacturing
The servicing discussion continued after the 2018 report.
In 2024, the FDA issued final guidance to clarify the difference between servicing and remanufacturing.
That guidance reinforced an important principle:
The label a company gives its work matters less than what the company actually does to the device.
If the work simply restores the device to its established safety and performance specifications, it may be servicing.
If the work significantly changes those specifications or intended use, it may be remanufacturing.
That distinction can change which federal requirements apply.
Why Quality Systems Still Matter
The fact that the FDA did not impose a new servicing-specific regulatory program does not mean quality does not matter.
Independent service companies should still have disciplined processes.
Good service practices may include:
- Accurate equipment identification
- Clear repair records
- Technician training
- Parts traceability
- Defined test procedures
- Post-repair verification
- Proper handling of safety systems
- Cybersecurity awareness where applicable
The goal should be repeatable, documented work.
Not guesswork.
What Should Clinics Look for in a Service Provider?
A clinic should evaluate a third-party provider the same way it would evaluate any technical partner.
Ask:
- Does the company know this platform?
- Can it be diagnosed before replacing parts?
- Does it document its findings?
- Does it explain what was repaired?
- Does it verify the repair afterward?
- Does it provide a written warranty?
- Can it explain where replacement parts came from?
Price matters.
But technical quality matters more.
Independent Parts Still Need to Be Appropriate
The FDARA report also should not be interpreted as saying that every aftermarket or used part is automatically acceptable.
A replacement component should be suitable for the application.
The technician should understand:
- Compatibility
- Specifications
- Condition
- Quality
- Installation requirements
A qualified aftermarket component is not automatically a bad part.
Likewise, an OEM label does not remove the need for proper diagnosis.
What FDARA Section 710 Means for Clinics
For medical and aesthetic practices, the practical message is simple.
You have service options.
You can evaluate OEM and qualified independent providers based on:
- Technical ability
- Response time
- Documentation
- Parts access
- Warranty
- Cost
- Support
The FDA’s report did not establish an OEM-only service model.
At the same time, it did not say that every person with a toolbox is qualified to service medical equipment.
Choose based on capability.
What FDARA Section 710 Means for Service Companies
Independent service creates responsibility.
A professional service company should be able to explain:
- What failed
- How it was diagnosed
- What was repaired
- Which parts were used
- How the repair was verified
That becomes even more important when servicing older medical equipment.
The goal is not to redesign the device.
The goal is to return it to proper operation.
The Report Did Not End the Debate
The 2018 FDA report was not the final word on medical-device servicing.
The FDA has continued working on:
- Servicing
- Remanufacturing
- Quality systems
- Cybersecurity
- Device maintenance information
In 2024, the agency finalized its remanufacturing guidance.
In 2026, the FDA’s updated Quality Management System Regulation also took effect for entities subject to those manufacturer requirements.
That makes the servicing-versus-remanufacturing distinction even more important.
What Is the Real Lesson From FDARA Section 710?
FDARA Section 710 did not declare third-party service universally safe.
It did something more important.
The FDA reviewed the available evidence and did not find a widespread servicing problem that justified imposing additional burdensome regulations at that time.
It also recognized that both OEM and third-party providers can perform high-quality service and that third-party servicing is important to the U.S. healthcare system.
Today, the bigger question is not simply:
“OEM or independent?”
It is:
“Was the device properly diagnosed, repaired to the correct specifications, tested, and documented?”
Good service is defined by the work—not the logo on the technician’s shirt.
Need independent service for a medical or aesthetic laser?
Call The Laser Professionals at 561-203-9776 or email [email protected].
We provide component-level repair, preventative maintenance, output testing, handpiece service, onsite support, and nationwide medical and aesthetic laser service.
The Laser Professionals — Technicians First. Sellers Second.
